Leuprolide and interstitial lung disease Patient Reports February 12, 2012

Leuprolide Side Effects Report #5863027-9
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Aug 18, 2008. Male patient, 83 years of age, was diagnosed with prostate cancer stage iv and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: condition aggravated, interstitial lung disease, prostatic specific antigen increased. Leuprolide dosage: unknown. During the same period patient was treated with BICALUTAMIDE, FLUTAMIDE, ESTRAMUSTINE PHOSPHATE. Patient died on 01/08/2008.

Leuprolide Side Effects Report #5534113-8
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Nov 26, 2007. Male patient, 75 years of age, was diagnosed with prostate cancer stage iv and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: benign prostatic hyperplasia, chest x-ray abnormal, condition aggravated, crepitations, dyspnoea exertional, hypoxia, interstitial lung disease, prostate cancer , urge incontinence. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with BLOFRESS, CASODEX, FLIVAS, BUFFERIN. Patient died.

Leuprolide Side Effects Report #4948459-5
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Mar 09, 2006. Male patient, 74 years of age, was diagnosed with prostate cancer stage iv and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: cardiac arrest , haematuria, interstitial lung disease. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D); SUBCUTANEOUS. During the same period patient was treated with LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, CHLORMADINONE ACETATE, HONVAN, CASODEX. Patient died.

Leuprolide Side Effects Report #5862960-1
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Aug 18, 2008. Male patient, 78 years of age, was diagnosed with prostate cancer stage iii, hypertension, osteoporosis , constipation , antibiotic prophylaxis and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: constipation , interstitial lung disease, osteoporosis . Leuprolide dosage: unknown. During the same period patient was treated with BICALUTAMIDE, AMLODIPINE BESYLATE, ALFACALCIDOL, MAGNESIUM OXIDE, ISONIAZID, BACTRIM, PYRIDOXAL PHOSPHATE. Patient was hospitalized. Patient recovered.


Leuprolide Side Effects Report #5996817-2
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Dec 01, 2008. Male patient, 78 years of age, was diagnosed with prostate cancer stage iii, hypertension, osteoporosis , constipation , antibiotic prophylaxis and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: constipation , injection site erosion, injection site erythema, injection site induration, interstitial lung disease, osteoporosis . Leuprolide dosage: unknown. During the same period patient was treated with BICALUTAMIDE, AMLODIPINE BESYLATE, ALFACALCIDOL, MAGNESIUM OXIDE, ISONIAZID, BACTRIM, PYRIDOXAL PHOSPHATE. Patient was hospitalized. Patient recovered.

Leuprolide Side Effects Report #6087228-2
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Feb 12, 2009. Male patient, 78 years of age, was diagnosed with prostate cancer stage iii, hypertension, osteoporosis , constipation , antibiotic prophylaxis and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: constipation , injection site erosion, injection site erythema, injection site induration, interstitial lung disease, osteoporosis . Leuprolide dosage: unknown. During the same period patient was treated with CASODEX, AMLODIN, ONEALFA, MAGMITT, ISONIAZID, SULFAMETHOXAZOLE AND TRIMETHOPRIM, PYRIDOXAL PHOSPHATE. Patient was hospitalized. Patient recovered.

Leuprolide Side Effects Report #5282645-2
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Mar 21, 2007. Male patient, 77 years of age, was diagnosed with prostate cancer stage iii and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: condition aggravated, interstitial lung disease. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK). During the same period patient was treated with CASODEX, PREDNISOLONE, OMEPRAL, GASTROM. Patient was hospitalized. Patient died.

Leuprolide Side Effects Report #5314693-8
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Apr 24, 2007. Male patient, 77 years of age, was diagnosed with prostate cancer stage iii and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: condition aggravated, infection , interstitial lung disease. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with CASODEX, PREDNISOLONE, OMEPRAL. Patient was hospitalized. Patient died.

Leuprolide Side Effects Report #5377780-4
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on June 25, 2007. Male patient, 77 years of age, was diagnosed with prostate cancer stage iii and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: candida serology positive, condition aggravated, interstitial lung disease, no therapeutic response. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with CASODEX, PREDNISOLONE, OMEPRAL, GASTROM. Patient was hospitalized. Patient died.


Leuprolide Side Effects Report #5806312-9
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on June 26, 2008. Male patient, 81 years of age, was diagnosed with prostate cancer stage ii, bladder cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: interstitial lung disease, respiratory failure. Leuprolide dosage: unknown. During the same period patient was treated with BICALUTAMIDE, ACEGLATONE. Patient was hospitalized. Patient recovered.

Leuprolide Side Effects Report #5565869-6
Leuprolide side effect was reported by a Physician from JAPAN on Dec 07, 2007. Male patient, 76 years of age, weighting 156.5 lb, was diagnosed with prostate cancer stage ii and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: interstitial lung disease. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK). During the same period patient was treated with NORVASC, PREDNISOLONE. Patient died.

Leuprolide Side Effects Report #5569741-7
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Dec 13, 2007. Male patient, 76 years of age, was diagnosed with prostate cancer stage ii and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: interstitial lung disease, respiratory failure. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with NORVASC, PREDNISOLONE. Patient was hospitalized. Patient died.

Leuprolide Side Effects Report #5578472-9
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Dec 21, 2007. Male patient, 76 years of age, was diagnosed with prostate cancer stage ii and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: bacterial infection , interstitial lung disease, myocardial ischaemia, pleural effusion, respiratory failure, sputum culture positive, staphylococcal infection . Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with NORVASC, PREDINONE. Patient was hospitalized. Patient died.

Leuprolide Side Effects Report #5793636-7
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on June 20, 2008. Male patient, 75 years of age, was diagnosed with prostate cancer stage i, lip and/or oral cavity cancer, angina pectoris, hypertension and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: interstitial lung disease, lip and/or oral cavity cancer. Leuprolide dosage: unknown. During the same period patient was treated with LEUPROLIDE ACETATE, DOCETAXEL, ASPIRIN, CLARUTE R. Patient died on 08/09/2007.


Leuprolide Side Effects Report #5831507-8
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on July 23, 2008. Male patient, 75 years of age, was diagnosed with prostate cancer stage i, lip and/or oral cavity cancer, angina pectoris, hypertension and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: interstitial lung disease, lip and/or oral cavity cancer, oral neoplasm. Leuprolide dosage: unknown. During the same period patient was treated with LEUPROLIDE ACETATE, DOCETAXEL, ACETYLSALICYLIC ACID SRT, CLARUTE R. Patient died on 08/09/2007.

Leuprolide Side Effects Report #5858826-3
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Aug 19, 2008. Male patient, 75 years of age, was diagnosed with prostate cancer stage i, lip and/or oral cavity cancer, angina pectoris, hypertension and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: interstitial lung disease, laryngeal cancer, lip and/or oral cavity cancer, oral neoplasm. Leuprolide dosage: unknown. During the same period patient was treated with LEUPROLIDE ACETATE, DOCETAXEL, ACETYLSALICYLIC ACID SRT, CLARUTE R. Patient was hospitalized. Patient died on 08/09/2007.

Leuprolide Side Effects Report #4942994-1
Leuprolide side effect was reported by a Health Professional from JAPAN on Mar 03, 2006. Male patient, 88 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: dyspnoea, interstitial lung disease, lymphocyte stimulation test positive. Leuprolide dosage: 11.25 MG. During the same period patient was treated with LEUPROLIDE ACETATE, CASODEX. Patient died.

Leuprolide Side Effects Report #4948460-1
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Mar 08, 2006. Male patient, 88 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: interstitial lung disease, lymphocyte stimulation test negative, malaise, pneumonia chlamydial, sputum abnormal. Leuprolide dosage: 11.25 MG (11.25 NG 1 UB 12 WK); SUBCUTANEOUS. During the same period patient was treated with CASODEX, FLIVAS, POLLAKISU, LANIRAPID, EBASTEL, ZENBRON, EXCELASE, GASMOTIN. Patient died.

Leuprolide Side Effects Report #4967362-8
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Mar 27, 2006. Male patient, 88 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: bacterial test positive, candidiasis, interstitial lung disease, lymphocyte stimulation test positive, malaise, pneumonia , pneumonia chlamydial, staphylococcal infection . Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK). During the same period patient was treated with CASODEX, FLIVAS, POLLAKISU, LANIRAPID, EBASTEL, ZENBRON, EXCELASE, GASMOTIN. Patient died.


Leuprolide Side Effects Report #5165521-5
Leuprolide side effect was reported by a Physician from JAPAN on Nov 22, 2006. Male patient, 85 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: haemoptysis, interstitial lung disease, no therapeutic response, pleural effusion. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D) SUBCUTANEOUS. During the same period patient was treated with CASODEX, RESTREAM, EVIPROSTAT, ALESION, ZANTAC, LAXOBERON. Patient was hospitalized. Patient died.

Leuprolide Side Effects Report #5952866-1
Leuprolide side effect was reported by a Physician from JAPAN on Nov 07, 2008. Male patient, 85 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: interstitial lung disease, palpitations. Leuprolide dosage: unknown. During the same period patient was treated with BICALUTAMIDE. Patient was hospitalized. Patient recovered.

Leuprolide Side Effects Report #5046833-2
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on June 23, 2006. Male patient, 85 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: chest x-ray abnormal, dyspnoea, haemoptysis, interstitial lung disease, pleural effusion. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D). During the same period patient was treated with CASODEX, RESTREAM, EVIPROSTAT, ALESION, ZANTAC, LAXOBERON. Patient was hospitalized. Patient died.

Leuprolide Side Effects Report #4875295-0
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Dec 29, 2005. Male patient, 81 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: interstitial lung disease, pulmonary oedema, respiratory arrest. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with CASODEX, LOXONIN, SELBEX. Patient was hospitalized. Patient died.

Leuprolide Side Effects Report #6012501-3
Leuprolide side effect was reported by a Physician from JAPAN on Dec 10, 2008. Male patient, 80 years of age, was diagnosed with prostate cancer , hyperuricaemia, thrombosis prophylaxis, angina pectoris, insomnia and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: interstitial lung disease. Leuprolide dosage: unknown. During the same period patient was treated with LEUPROLIDE ACETATE, BICALUTAMIDE, ALLOPURINOL, WARFARIN POTASSIUM, VERAPAMIL HYDROCHLORIDE, ZOLPIDEM TARTRATE. Patient recovered.


Leuprolide Side Effects Report #6057900-9
Leuprolide side effect was reported by a Physician from JAPAN on Jan 22, 2009. Male patient, 80 years of age, was diagnosed with prostate cancer , hyperuricaemia, thrombosis prophylaxis, angina pectoris, insomnia and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: interstitial lung disease. Leuprolide dosage: unknown. During the same period patient was treated with LEUPROLIDE ACETATE, CASODEX, ALLOPURINOL, WARFARIN POTASSIUM, VERAPAMIL HYDROCHLOIRDE, MYSLEE. Patient recovered.

Leuprolide Side Effects Report #5640450-9
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Feb 20, 2008. Male patient, 79 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: anorexia, computerised tomogram abnormal, cough, dyspnoea, interstitial lung disease, malaise, pneumocystis jiroveci pneumonia, productive cough, pseudomonas infection. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with CASODEX, PIROAN, BUFFERIN, NEUQUINON, ACTOSIN, TANATRIL, VASTAREL F, LOXONIN. Patient was hospitalized. Patient died.

Leuprolide Side Effects Report #5675552-4
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Mar 12, 2008. Male patient, 79 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: interstitial lung disease, pneumocystis jiroveci pneumonia, pseudomonas infection, respiratory failure. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 1 12 WK) SUBCUTANEOUS. During the same period patient was treated with CASODEX, PIROAN, BUFFERIN, NEUQUINON, ACTOSIN, TANATRIL, VASATREL F, LOXONIN. Patient was hospitalized. Patient died.

Leuprolide Side Effects Report #5700964-X
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Apr 01, 2008. Male patient, 79 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: anorexia, interstitial lung disease, klebsiella infection, pneumocystis jiroveci pneumonia, pseudomonas infection, respiratory failure. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with CASODEX, PIROAN, BUFFERIN, NEUQUINON, ACTOSIN, TANATRIL, VASTAREL F, LOXONIN. Patient was hospitalized. Patient died.

Leuprolide Side Effects Report #4896896-X
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Jan 23, 2006. Male patient, 75 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: atrioventricular block, interstitial lung disease, myocardial infarction. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D). During the same period patient was treated with TECHNIS, RIZE, MIYA BM, MAGNESIUM OXIDE, GLYCYOL, URSO, BEZATOL, FAMOTIDINE. Patient was hospitalized. Patient died.


Leuprolide Side Effects Report #4906939-2
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Feb 02, 2006. Male patient, 75 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: atrioventricular block, cardiac arrest , disseminated intravascular coagulation, fungal infection , gastric haemorrhage, gastric ulcer, interstitial lung disease, lymphocyte stimulation test positive, myocardial infarction. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D), SUBCUTANEOUS. During the same period patient was treated with TECHNIS, RIZE, MIYA BM, MAGNESIUM OXIDE, GLYCYOL, URSO, BEZATOL, FAMOTIDINE. Patient was hospitalized. Patient died.

Leuprolide Side Effects Report #5679874-2
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Mar 19, 2008. Male patient, 74 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: blood immunoglobulin e increased, cell marker increased, disseminated intravascular coagulation, dyspnoea, interstitial lung disease, metastases to lung, pneumothorax. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with CHLORMADINONE ACETATE. Patient was hospitalized. Patient died.

Leuprolide Side Effects Report #5711399-8
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Apr 10, 2008. Male patient, 74 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: blood immunoglobulin e increased, cell marker increased, collagen disorder, disseminated intravascular coagulation, interstitial lung disease, surfactant protein increased. Leuprolide dosage: 11.25MG (11.25 MG, 1 IN 12 WK); SUBCUTANEOUS. During the same period patient was treated with CHLORMADINONE ACETATE. Patient was hospitalized. Patient died.

Leuprolide Side Effects Report #4996462-1
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Feb 12, 2006. Male patient, 74 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: cardiac arrest , interstitial lung disease, metastases to lung, pleural effusion. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D) SUBCUTANEOUS - SEE IMAGE. During the same period patient was treated with LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, CHLORMADINONE ACETATE, HONVAN, CASODEX. Patient died.

Leuprolide Side Effects Report #5179050-6
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Dec 04, 2006. Male patient, 72 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: crepitations, dyspnoea, interstitial lung disease, pneumothorax, rales. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D). During the same period patient was treated with CASODEX. Patient was hospitalized. Patient died.


Leuprolide Side Effects Report #6082534-X
Leuprolide side effect was reported by a Physician from JAPAN on Feb 09, 2009. Male patient, 72 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: cough, interstitial lung disease, mobility decreased. Leuprolide dosage: unknown. Patient was hospitalized. Patient recovered.

Leuprolide Side Effects Report #6092099-4
Leuprolide side effect was reported by a Physician from JAPAN on Feb 19, 2009. Male patient, 72 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: cough, interstitial lung disease, mobility decreased. Leuprolide dosage: unknown. Patient was hospitalized. Patient recovered.

Leuprolide Side Effects Report #4662993-7
Leuprolide side effect was reported by a Consumer or non-health professional from on May 10, 2005. Male patient, 72 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: interstitial lung disease, pneumothorax. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D). During the same period patient was treated with CASODEX. Patient was hospitalized. Patient died.

Leuprolide Side Effects Report #4704057-X
Leuprolide side effect was reported by a Consumer or non-health professional from on June 27, 2005. Male patient, 72 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: infection , interstitial lung disease, pneumothorax. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D) SUBCUTANEOUS. During the same period patient was treated with CASODEX. Patient was hospitalized. Patient died.

Leuprolide Side Effects Report #5368355-1
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on June 14, 2007. Male patient, 68 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: interstitial lung disease, pulmonary alveolar haemorrhage. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D) SUBCUTANEOUS. During the same period patient was treated with CASODEX, HARNAL, MYSLEE. Patient was hospitalized. Patient died.


Leuprolide Side Effects Report #5581233-8
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Dec 21, 2007. Male patient, 68 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: interstitial lung disease, polymyositis, pulmonary alveolar haemorrhage, pulmonary mycosis. Leuprolide dosage: 3.75 MG (3.75 MG,1 IN 28 D) SUBCUTANEOUS. During the same period patient was treated with CASODEX, HARNAL, MYSLEE. Patient was hospitalized. Patient died.

Leuprolide Side Effects Report #5834664-2
Leuprolide side effect was reported by a Physician from JAPAN on July 25, 2008. Male patient, 67 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: interstitial lung disease, nocturnal dyspnoea. Leuprolide dosage: unknown. During the same period patient was treated with LEUPROLIDE ACETATE. Patient recovered.

Leuprolide Side Effects Report #4939442-4
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Feb 28, 2006. Male patient, 67 years of age, was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: interstitial lung disease. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D), PER ORAL. During the same period patient was treated with CHLORMADINONE ACETATE. Patient was hospitalized. Patient died.

Leuprolide Side Effects Report #5340058-9
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on May 22, 2007. Male patient was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: infection in an immunocompromised host, interstitial lung disease, respiratory failure. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D) SUBCUTANEOUS. Patient died.

Leuprolide Side Effects Report #5363115-X
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on June 12, 2007. Male patient was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: immunosuppression, interstitial lung disease, respiratory failure. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D) SUBCUTANEOUS. Patient died.

Leuprolide Side Effects Report #5123376-9
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Oct 02, 2006. Male patient was diagnosed with prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: interstitial lung disease. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) PER ORAL. During the same period patient was treated with CASODEX. Patient was hospitalized. Patient died.

Leuprolide Side Effects Report #5048582-3
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on June 28, 2006. Male patient, 81 years of age, was diagnosed with metastases to bone, prostate cancer  and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: cardiac failure acute, interstitial lung disease, pneumonia , pulmonary oedema, respiratory failure. Leuprolide dosage: 11.25 MG. During the same period patient was treated with LEUPROLIDE ACETATE, CASODEX, LOXONIN, SELBEX. Patient was hospitalized. Patient died.

Leuprolide Side Effects Report #4830515-3
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Nov 10, 2005. Female patient, 53 years of age, was diagnosed with menorrhagia and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: arthralgia, disease recurrence, interstitial lung disease, menorrhagia, oedema peripheral, polymyositis. Leuprolide dosage: 1.88 MG (1.88 MG, 1 IN 28 D) SUBCUTANEOUS. During the same period patient was treated with LEUPROLIDE ACETATE, BENET, GASTER. Patient was hospitalized. Patient recovered.

Leuprolide Side Effects Report #4637988-X
Leuprolide side effect was reported by a Health Professional from on Apr 12, 2005. Male patient, 70 years of age, was treated with Leuprolide. After drug was administered, patient experienced the following side effects: interstitial lung disease. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D). During the same period patient was treated with BACTRIM. Patient died.